
BLUEMOKY (S Size) Modish Round Progressive Prescription Glasses Myopia Eyewear Handmade Acetate Optical Eyeglasses for Unisex
1+ sold
£36.29£72.58
50% OFFBuy on AliExpress
You will be redirected to AliExpress to complete your purchase
Specifications
- Brand Name
- BLUEMOKY
- Gender
- Men, Men&Women
- Frame Material
- Acetate
- High-concerned chemical
- None
- Lenses Material
- Acrylic
- Origin
- Mainland China
- Item Type
- Prescription Glasses
- Place Of Origin
- China (mainland)
- Model Number
- YHB8048
- Certification
- CE
- Boxes Included
- Yes
- Glasses Shape
- Round Prescription Glasses
- Prescription Lens
- Customizable
- Particular Attention 1
- Prescriptions for Hyperopia additional payment of $10
- Lens Function Choice
- Anti Blue Light
- Lens Function Choice 2
- Photochromic
- Lens Function Choice 3
- Progressive
- Lens Function Choice 4
- Astigmatic, Myopia, Hyperopia
Product Description
Pros & Cons
Pros
- Handmade acetate frames for stylish round unisex design
- Customizable progressive lenses for myopia/astigmatism/hyperopia
- Multiple functions: anti-blue light, photochromic options
- CE certified with included boxes for protection
Cons
- S size only, may not fit larger faces
- Extra $10 for hyperopia lenses
- Acrylic lenses less premium than glass
- Prescription customization requires accurate details
Common Questions
What frame and lens materials for BLUEMOKY round progressive prescription glasses?
Handmade acetate frame, acrylic lenses; S size unisex eyewear.
Lens functions available for these myopia eyeglasses?
Anti blue light, photochromic, progressive, astigmatic/myopia/hyperopia; customizable prescription.
Gender and style of these modish round optical glasses?
Unisex men & women; round prescription glasses shape, CE certified.
Additional costs for hyperopia prescriptions on these acetate glasses?
Hyperopia prescriptions require additional $10 payment.
Origin and boxes included for BLUEMOKY YHB8048 model?
Mainland China origin; boxes included yes.
Product information last updated on December 5, 2025
